Why the study?
The study was conducted to determine the relationship between the serum taurine/alanine ratio and heart rate variability indicators in patients with postinfarction cardiosclerosis and type 2 diabetes mellitus.
Is there a relationship between the serum taurine/alanine ratio and heart rate variability in patients with postinfarction cardiosclerosis and type 2 diabetes?
Is there a relationship between the serum taurine/alanine ratio and heart rate variability in patients with postinfarction cardiosclerosis and type 2 diabetes?
A lower serum taurine/alanine ratio is associated with reduced heart rate variability in patients with postinfarction cardiosclerosis and type 2 diabetes.
The aim of the article : to determine the relationship of the ratio taurine/alanine (Tau/Ala) serum indicators of heart rate variability (HRV) in patients with postinfarction cardiosclerosis (PICS) and diabetes mellitus type 2 (DM 2). Materials and methods: we examined 87 patients with PICS and DM 2 – 50 women and 37 men, median age of the patients was 65.2 years (microtile interval 61-69 years). Amino acids were determined and the ratio between them. According to the results of Holter ECG monitoring (of HMCG) evaluated HRV. Results: in patients with PICS compared with healthy individuals observed a significant decrease in the blood levels of Tau/Ala (at 51.01%, p<0.001). The presence of comorbid diabetes is accompanied by more significant decrease in Tau/Ala (for the accounting period 82.22%, p<0.001) compared to healthy individuals. Between Tau/Ala and SDNN, LF, TP, VLF power of communication has been high, between Tau/Ala and RMSSD, HF, pNN 50.%, ULF, – moderate strength. Conclusions: the lower values of Tau/Ala in the blood of patients Pxs diabetes compared with patients without disorders of carbohydrate metabolism, accompanied by a decrease in spectral and temporal parameters of HRV, but that does not mean a causal relationship, may be associated with pathogenetic mechanisms of disorders of carbohydrate metabolism and requires further research.
No takes yet. Share an insight, caveat, or question.
J. Belikova (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: